Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain

被引:20
|
作者
Jimenez-Garcia, Rodrigo [1 ]
Hernandez-Barrera, Valentin [1 ]
Rodriguez-Rieiro, Cristina [1 ]
Lopez de Andres, Ana [1 ]
de Miguel-Diez, Javier [2 ]
Jimenez-Trujillo, Isabel [1 ]
Gil de Miguel, Angel [1 ]
Carrasco-Garrido, Pilar [1 ]
机构
[1] Rey Juan Carlos Univ, Prevent Med Unit, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Madrid, Spain
关键词
Diabetes; H1N1; hospitalizations; Influenza A; obesity; pandemic; CRITICALLY-ILL PATIENTS; 2009; H1N1; INFLUENZA; MORTALITY; OUTCOMES;
D O I
10.1111/j.1750-2659.2012.00419.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives To describe and analyze the clinical characteristics and outcomes for all patients with diabetes who were hospitalized with laboratory-confirmed A(H1N1)pdm09 infections in Spain during 2009. Methods Observational retrospective study using data collected by the Spanish National Hospital Discharge Database. We selected all admissions with diagnosis ICD-9-CM code 488 center dot 1 [A(H1N1)pdm09]. Discharges were grouped as follows: no diabetes, Type1 and Type 2 diabetes. Underlying medical conditions and risk factors included all those that constitute an indication for annual influenza vaccination, pregnancy, and obesity. The outcome variables analyzed were in-hospital case fatality risk, length of hospital stay, and costs. Results The total number of persons hospitalized with A(H1N1)pdm09 was 11499. Of those, 97 suffered Type 1 and 936 Type 2, giving an overall prevalence of diabetes of 9%. The most common underlying medical condition among Type 2 subjects was obesity (26 center dot 8%), and for Type 1 renal disease (10 center dot 3%). In-hospital mortality was 2 center dot 1% among Type 1 patients, 3 center dot 8% among Type 2 patients, and 2 center dot 3% among non-diabetics; after multivariate analysis, diabetes was not a factor independently associated with dying during hospitalization for A(H1N1)pdm09. Independent factors increasing the risk of death among diabetic patients included age (OR 1 center dot 03; 95% CI1 center dot 011 center dot 05), hematological disorders (OR 3 center dot 49; 95% CI, 1 center dot 468 center dot 37), and obesity (OR 1 center dot 88; 95% CI1 center dot 073 center dot 92). Conclusions Among individuals hospitalized in Spain with A(H1N1)pdm09 infections, the age-specific prevalence of diabetes was higher than the general population in most age groups. The results of multivariate analysis suggest that possibly concomitant conditions such as obesity increase the risk of dying from the infection, but not diabetes itself.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
  • [21] Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
    Simon, Marie
    Hernu, Romain
    Cour, Martin
    Casalegno, Jean-Sebastien
    Lina, Bruno
    Argaud, Laurent
    EMERGING INFECTIOUS DISEASES, 2013, 19 (06) : 1005 - 1007
  • [22] Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
    Mereckiene, J.
    Cotter, S.
    Weber, J. T.
    Nicoll, A.
    D'Ancona, F.
    Lopalco, P. L.
    Johansen, K.
    Wasley, A. M.
    Jorgensen, P.
    Levy-Bruhl, D.
    Giambi, C.
    Stefanoff, P.
    Dematte, L.
    O'Flanagan, D.
    EUROSURVEILLANCE, 2012, 17 (04) : 18 - 27
  • [23] Outcomes of infants born to women with influenza A(H1N1)pdm09
    Newsome, Kim
    Alverson, C. J.
    Williams, Jennifer
    McIntyre, Anne F.
    Fine, Anne D.
    Wasserman, Cathy
    Lofy, Kathryn H.
    Acosta, Meileen
    Louie, Janice K.
    Jones-Vessey, Kathleen
    Stanfield, Valoree
    Yeung, Alice
    Rasmussen, Sonja A.
    BIRTH DEFECTS RESEARCH, 2019, 111 (02): : 88 - 95
  • [24] Risk Factors for Influenza A(H1N1) pdm09 among Students, Beijing, China
    Zheng, Yang
    Duan, Wei
    Yang, Peng
    Zhang, Yi
    Wang, Xiaoli
    Zhang, Li
    Liyanage, Surabhi S.
    Wang, Quanyi
    EMERGING INFECTIOUS DISEASES, 2013, 19 (02) : 309 - 312
  • [25] Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
    Ge, Pan
    Ross, Ted M.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 519 - 526
  • [26] New patterns of A(H1N1)pdm09 influenza in the Southern Hemisphere
    David Vandroux
    Elise Brottet
    Lionel Ursulet
    Marion Angue
    Julien Jabot
    Laurent Filleuil
    Bernard-Alex Gauzere
    Intensive Care Medicine, 2014, 40 : 131 - 132
  • [27] New patterns of A(H1N1)pdm09 influenza in the Southern Hemisphere
    Vandroux, David
    Brottet, Elise
    Ursulet, Lionel
    Angue, Marion
    Jabot, Julien
    Filleuil, Laurent
    Gauzere, Bernard-Alex
    INTENSIVE CARE MEDICINE, 2014, 40 (01) : 131 - +
  • [28] Transmission of the First Influenza A(H1N1) pdm09 Pandemic Wave in Australia Was Driven by Undetected Infections: Pandemic Response Implications
    Fielding, James E.
    Kelly, Heath A.
    Glass, Kathryn
    PLOS ONE, 2015, 10 (12):
  • [29] Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09
    Louie, Janice K.
    Yang, Samuel
    Acosta, Meileen
    Yen, Cynthia
    Samuel, Michael C.
    Schechter, Robert
    Guevara, Hugo
    Uyeki, Timothy M.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (09) : 1198 - 1204
  • [30] OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS WITH SEVERE ARDS DUE TO INFLUENZA A(H1N1) PDM09 VIRUS
    Tignanelli, Christopher J.
    Wiktor, Arek J.
    Vatsaas, Cory J.
    Sachdev, Gaurav
    Heung, Michael
    Park, Pauline K.
    Raghavendran, Krishnan
    Napolitano, Lena M.
    AMERICAN JOURNAL OF CRITICAL CARE, 2018, 27 (01) : 67 - 73